Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 17 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Field emission cathode structure
Fabrication method of semiconductor device and fabrication method of dynamic threshold transistor
Efficient relay automatic repeat request procedure in broadband wireless access system
Packet transmission method, apparatus, and network system
LED package with top and bottom electrodes
Lock monitoring
Methods and systems for enabling community-tested security features for legacy applications
  Randomly Featured Patents
Portable and programmable medical device
Wireless diagnostic system and method
Manifold for supplying liquids
Modular jack having improved grounding plate
Method and apparatus for providing a shell component incorporating a porous ingrowth material and liner
Manipulable vacuum extractor for childbirth and method of using the same
Optical calibration apparatus and procedure
Eyeball return fitting for pool or spa
Cutting insert
Method of wire bonding over active area of a semiconductor circuit